Literature DB >> 2851723

DNase I hypersensitivity is independent of endogenous topoisomerase II activity during chicken erythrocyte differentiation.

M T Muller1, V B Mehta.   

Abstract

Endogenous topoisomerase II cleavage sites were mapped in the chicken beta A-globin gene of 12- to 14-day embryonic erythrocytes. A major topoisomerase II catalytic site was mapped to the 5' end of the globin gene which contained a nucleosome-free and DNase I-hypersensitive site and additional but minor sites were mapped to the second intron and 3' of the gene to a tissue-specific enhancer. Cleavage sites, mapped in situ by indirect end labeling, were aligned to single-base-pair resolution by comparison to a consensus sequence derived for vertebrate topoisomerase II catalytic sites. In contrast to embryonic erythrocytes, endogenous topoisomerase II cleavages were not detected in erythrocytes from peripheral blood of adult chickens; therefore, as the transcriptional activity of the beta A-globin gene declines during terminal differentiation of erythrocytes, the activity of topoisomerase II in situ declines as well, despite the fact that DNase I hypersensitivity persists. The results showed that DNase I-hypersensitive chromatin can be maintained in the absence of topoisomerase II activity and suggested that topoisomerase II acts at hypersensitive sites because of an inherent attraction to some preexisting combination of DNA sequence or chromatin structure associated with DNase I-hypersensitive regions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851723      PMCID: PMC365421          DOI: 10.1128/mcb.8.9.3661-3669.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  Simple procedure for isolation of DNA, RNA and protein fractions from cultured animal cells.

Authors:  J L Shaw; J Blanco; G C Mueller
Journal:  Anal Biochem       Date:  1975-05-12       Impact factor: 3.365

2.  Chromosomal subunits in active genes have an altered conformation.

Authors:  H Weintraub; M Groudine
Journal:  Science       Date:  1976-09-03       Impact factor: 47.728

3.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  A 200 base pair region at the 5' end of the chicken adult beta-globin gene is accessible to nuclease digestion.

Authors:  J D McGhee; W I Wood; M Dolan; J D Engel; G Felsenfeld
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

5.  Tissue-specific exposure of chromatin structure at the 5' terminus of the rat preproinsulin II gene.

Authors:  C Wu; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

6.  DNA topoisomerases from rat liver: physiological variations.

Authors:  M Duguet; C Lavenot; F Harper; G Mirambeau; A M De Recondo
Journal:  Nucleic Acids Res       Date:  1983-02-25       Impact factor: 16.971

7.  Alpha-Globin-gene switching during the development of chicken embryos: expression and chromosome structure.

Authors:  H Weintraub; A Larsen; M Groudine
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

8.  Tissue-specific DNA cleavages in the globin chromatin domain introduced by DNAase I.

Authors:  J Stalder; A Larsen; J D Engel; M Dolan; M Groudine; H Weintraub
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

9.  Territorial limits and functional anatomy of the simian virus 40 replication origin.

Authors:  D J Bergsma; D M Olive; S W Hartzell; K N Subramanian
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

10.  Conformational constraints in nuclear DNA.

Authors:  P R Cook; I A Brazell
Journal:  J Cell Sci       Date:  1976-11       Impact factor: 5.285

View more
  12 in total

1.  Eukaryotic topoisomerase II cleavage of parallel stranded DNA tetraplexes.

Authors:  I K Chung; V B Mehta; J R Spitzner; M T Muller
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

2.  Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo.

Authors:  A Udvardy; P Schedl
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

3.  Topoisomerase II cleavage of herpes simplex virus type 1 DNA in vivo is replication dependent.

Authors:  S N Ebert; S S Shtrom; M T Muller
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats.

Authors:  J R Spitzner; I K Chung; M T Muller
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

5.  Distribution of topoisomerase II-mediated cleavage sites and relation to structural and functional landmarks in 830 kb of Drosophila DNA.

Authors:  R Miassod; S V Razin; R Hancock
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

6.  Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743.

Authors:  E J Martinez; T Owa; S L Schreiber; E J Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

7.  Inhibition of human topoisomerase II by anti-neoplastic benzazolo[3,2-alpha]quinolinium chlorides.

Authors:  P E Vivas-Mejía; O Cox; F A González
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

8.  Developmental regulation of topoisomerase II sites and DNase I-hypersensitive sites in the chicken beta-globin locus.

Authors:  M Reitman; G Felsenfeld
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

9.  Discrete regions of the avian beta-globin gene cluster have tissue-specific hypersensitivity to cleavage by sonication in nuclei.

Authors:  J S Reneker; T W Brotherton
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

10.  Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1.

Authors:  S N Ebert; D Subramanian; S S Shtrom; I K Chung; D S Parris; M T Muller
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.